AV Dosing and AE Management in Patients With Untreated CLL Part 2: Following Up After Initial Treatment

This Case-Based Exchange marks the second installment in our 3-part series, featuring discussions on the potential uses of fixed-duration acalabrutinib and venetoclax in chronic lymphocytic leukemia (CLL).

In the second video of this series, Mary Elizabeth DiLorenzo, MSN, RN, NP-BC, and Jamila Brutus, MSN, BSN, ANP-BC, RN, discuss the long-term follow-up of their previously discussed patient case. Together, their perspectives show the entire clinical journey of a patient with CLL and what to consider in both the short and long term when selecting treatment.

Download Transcript